1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

TherapeuticsMD Inc (TXMD) Files 10-K for the Fiscal Year Ended on December 31, 2017

February 23, 2018 | About:

TherapeuticsMD Inc (NASDAQ:TXMD) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. TherapeuticsMD Inc is a women's health care company focused on creating and commercializing products targeted exclusively for women. It is engaged in pre-commercialization activities for advanced hormone therapy pharmaceutical product. TherapeuticsMD Inc has a market cap of $1.16 billion; its shares were traded at around $5.37 with and P/S ratio of 66.29. TherapeuticsMD Inc had annual average EBITDA growth of 9.00% over the past five years.

For the last quarter TherapeuticsMD Inc reported a revenue of $4.12 million, compared with the revenue of $4.49 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $16.8 million, a decrease of 13.3% from the previous year. For the last five years TherapeuticsMD Inc had an average revenue growth rate of 33.3% a year.

The reported loss per diluted share was 37 cents for the year, compared with the loss per share of $0.22 in the previous year. The TherapeuticsMD Inc had an operating margin of -462.68%, compared with the operating margin of -466.28% a year before. The 10-year historical median operating margin of TherapeuticsMD Inc is -422.93%. The profitability rank of the company is 6 (out of 10).

At the end of the fiscal year, TherapeuticsMD Inc has the cash and cash equivalents of $127.1 million, compared with $131.5 million in the previous year. The company had no long term debt. The interest coverage to the debt is 1.8, which is not a favorable level. TherapeuticsMD Inc has a financial strength rank of 9 (out of 10).

At the current stock price of $5.37, TherapeuticsMD Inc is traded at 31.9% premium to its historical median P/S valuation band of $4.07. The P/S ratio of the stock is 66.29, while the historical median P/S ratio is 50.21. The stock lost 11.64% during the past 12 months.

For the complete 20-year historical financial data of TXMD, click here.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


bursaguru5Charles
HOLKLSUTop 20 Group Q3 2018 SHUT Sect
david.paige1stock%20screener%202.0
HOLKLSUEquity Income Group Q3 2018 SH
blovedayBest Backtest Results
muhua.huangmaster
mathew94Penny
mathew94Earning1Month
ralphdQuality Growth
salvatore34stock screener 2.0
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK